Jaspreet Grewal is an accomplished clinician, venture partner and published researcher. She brings nearly two decades of experience working with life science companies.
Jaspreet has held several positions in various healthcare roles, which has given her a broad skill set and a robust healthcare and investment network while working in Canada, the United States, the United Kingdom and Bermuda. She holds a Master’s in Clinical Vision Sciences from Georgetown University, an Executive Certificate in Public Health from Harvard University and an Executive MBA from the London School of Economics and Political Science. Her research interests have focused on phases one through four of drug and device trials within ophthalmology, paediatrics, CNS/mental health, oncology, gastroenterology, dermatology, pain and rehabilitation.
“I’m passionate about building ecosystems, supporting innovation and exploring the potential of new and forward-thinking therapies for patients and families,” Jaspreet says. “Operation Eyesight is focused on partnership and leading innovative approaches to care and programs. I’m excited to be part of that. Having interned at Operation Eyesight during my undergraduate years, it’s a delight to be able to continue my contribution at a Board level and work with such an impactful, global team.”
In addition to her volunteer role with Operation Eyesight, Jaspreet is the CEO of Knowde Group, a global life sciences consulting firm. She is also a Board Director with BioAlberta and Heroic Hearts Project Canada. Additionally, Jaspreet is an Expert Advisor with Innovate Calgary, the Global Life Sciences Consultant for Calgary Economic Development, Chair of the Clinical Research Association of Canada and a Founding Member of the Alberta Life Sciences Investment Committee.